UK Companies House feature
PHARMASPECTRA GROUP LTD
Cash
£5M
+21% vs 2023
Net assets
£15M
+126.4% vs 2023
Employees
14
-6.7% vs 2023
Profit before tax
-£18M
-22.9% vs 2023
Profile
- Company number
- 12084283
- Status
- Active
- Incorporation
- 2019-07-03
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62090
Net assets
3-year trend · vs UK AI & Enterprise SaaS median
Accounts
3-year trend · latest 2024-12-31
| Metric | Trend | 2023-01-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | — | £11,156,737 | £9,119,064 | |
| Operating profit | — | -£5,117,968 | -£7,803,816 | |
| Profit before tax | — | -£14,353,602 | -£17,641,152 | |
| Net profit | — | -£14,233,888 | -£16,795,118 | |
| Cash | — | £4,137,168 | £5,004,204 | |
| Total assets less current liabilities | — | -£55,693,300 | £14,676,876 | |
| Net assets | — | -£55,693,300 | £14,676,876 | |
| Equity | -£41,459,412 | -£55,693,300 | £14,676,876 | |
| Average employees | — | 15 | 14 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“On this basis, the directors have, at the time of approving these financial statements, a reasonable expectation that the business has adequate resources available to continue in operational existence, for the foreseeable future, being a period of not less than 12-months from approval of these financial statements. Therefore, the directors believe that it remains appropriate to prepare the financial statements on a going concern basis.”
Significant events
- “Waiver of intercompany loans by parent company amounting to £87,165,294, recognised as a capital contribution.”
- “Loss on sale of intangible assets amounting to $4,375,000.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JTC (UK) LIMITED | Corporate Secretary | 2023-06-29 | — | — |
| KOTCHIE, Robert | Director | 2022-08-01 | Jan 1979 | British |
| PARK, Graham Russell | Director | 2022-08-01 | Sep 1974 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LONG, Ben | Director | 2019-07-03 | 2022-08-01 |
| MOULDING, Jeremy Charles | Director | 2019-10-04 | 2022-08-01 |
| MURRELL, Andrew John | Director | 2019-10-04 | 2022-08-01 |
| NIGHTINGALE, Saloshnee | Director | 2019-09-20 | 2022-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Iqvia Ltd. | Corporate entity | Shares 75–100%, Voting 75–100% | 2024-12-02 | Active |
| Pharmaspectra Midco 2 Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-08-01 | Ceased 2024-12-02 |
| Mr Ben Long | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-03 | Ceased 2019-08-01 |
Filing timeline
Last 20 of 41 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-09-08 | AA | accounts | accounts with accounts type full |
| 2025-07-05 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-12-18 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-12-18 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-10-10 | AA | accounts | accounts with accounts type full |
| 2024-07-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-10-09 | AD02 | address | change sail address company with old address new address |
| 2023-10-09 | AA | accounts | accounts with accounts type full |
| 2023-10-06 | AP04 | officers | appoint corporate secretary company with name date |
| 2023-08-03 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-07-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-03 | AA | accounts | accounts with accounts type full |
| 2022-10-03 | MR04 | mortgage | mortgage satisfy charge full |
| 2022-09-14 | AD01 | address | change registered office address company with date old address new address |
| 2022-08-16 | TM01 | officers | termination director company with name termination date |
| 2022-08-16 | TM01 | officers | termination director company with name termination date |
| 2022-08-16 | TM01 | officers | termination director company with name termination date |
| 2022-08-16 | TM01 | officers | termination director company with name termination date |
| 2022-08-16 | AP01 | officers | appoint person director company with name date |
| 2022-08-16 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
4.22
SAFE
Altman Z″
- Working capital / Total assets 0.398 × 6.56 = +2.61
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.431 × 6.72 = -2.90
- Book equity / Total liabilities 4.293 × 1.05 = +4.51
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Composite activity score · components 0–100 · reference 2026-05-09
15.4
COLD
/ 100
- Filings velocity 17
- Capital events 0
- Officer churn 0
- Headcount trajectory 43
- Accounts trajectory 32
- 2 filing(s) in last 12 months
- Employees -7% YoY
- Turnover -18% YoY